retatrutide clinical trial philippines Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage trial, the company announced. In Retatrutide: Every Clinical Trial Result

Although discontinuation due to AEs does not always correlate directly with dose escalation [66], higher discontinuation rates have been reported in older adults [76]

The specific medication Wegovy (containing semaglutide) generally does not impact normal thyroid function in women

Reproductive outcomes are not the focus of the primary endpoints

Indeed, several studies have reported some level of sex-dependent differences in susceptibility to liver damage

Do not exceed the recommended daily serving as indicated on the package

Our diabetes experts stay at the forefront of their field by leading continuous research and clinical trials